rucaparib
clovis
['ariel4', 'ovarian', 'brca', 'rubraca']
rubraca improved progression-free survival in patients with relapsed ovarian cancer that harbors a deleterious brca1/2 mutation compared to chemotherapy, according to findings from the phase 3 ariel4 clinical trial. #esmo22 #ovariancancerawarenessmonth 
Cancer updates, research and education for patients with cancer, survivors and their caregivers to become empowered advocates in their journey.